IOVA logo

Iovance Biotherapeutics, Inc. (IOVA) Gross Profit

Annual Gross Profit:

$17.67M+$49.61M(+155.33%)
December 31, 2024

Summary

  • As of today, IOVA annual gross profit is $17.67 million, with the most recent change of +$49.61 million (+155.33%) on December 31, 2024.
  • During the last 3 years, IOVA annual gross profit has risen by +$31.65 million (+226.40%).
  • IOVA annual gross profit is now at all-time high.

Performance

IOVA Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOVAincome statement metrics

Quarterly Gross Profit:

-$2.95M+$3.12M(+51.42%)
June 30, 2025

Summary

  • As of today, IOVA quarterly gross profit is -$2.95 million, with the most recent change of +$3.12 million (+51.42%) on June 30, 2025.
  • Over the past year, IOVA quarterly gross profit has increased by +$2.69 million (+47.66%).
  • IOVA quarterly gross profit is now -113.41% below its all-time high of $22.01 million, reached on December 31, 2024.

Performance

IOVA Quarterly Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOVAincome statement metrics

TTM Gross Profit:

$26.10M+$2.69M(+11.48%)
June 30, 2025

Summary

  • As of today, IOVA TTM gross profit is $26.10 million, with the most recent change of +$2.69 million (+11.48%) on June 30, 2025.
  • Over the past year, IOVA TTM gross profit has increased by +$66.90 million (+163.98%).
  • IOVA TTM gross profit is now at all-time high.

Performance

IOVA TTM Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOVAincome statement metrics

Gross Profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

IOVA Gross Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+155.3%+47.7%+164.0%
3Y3 Years+226.4%+43.3%+224.2%
5Y5 Years+317.5%-71.8%+422.2%

IOVA Gross Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+155.3%-113.4%+78.3%at high+160.9%
5Y5-Yearat high+155.3%-113.4%+78.3%at high+160.9%
All-TimeAll-Timeat high+155.3%-113.4%+78.3%at high+160.9%

IOVA Gross Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$2.95M(+51.4%)
$26.10M(+11.5%)
Mar 2025
-
-$6.08M(-127.6%)
$23.41M(+32.5%)
Dec 2024
$17.67M(+155.3%)
$22.01M(+67.7%)
$17.67M(+198.5%)
Sep 2024
-
$13.12M(+332.6%)
-$17.94M(+56.0%)
Jun 2024
-
-$5.64M(+52.3%)
-$40.80M(+4.9%)
Mar 2024
-
-$11.82M(+13.1%)
-$42.88M(-16.7%)
Dec 2023
-$31.94M(-51.1%)
-$13.60M(-39.6%)
-$36.75M(-27.3%)
Sep 2023
-
-$9.74M(-26.2%)
-$28.86M(-18.7%)
Jun 2023
-
-$7.72M(-35.5%)
-$24.33M(-11.5%)
Mar 2023
-
-$5.70M(+0.2%)
-$21.81M(-3.4%)
Dec 2022
-$21.14M(-51.2%)
-$5.71M(-9.7%)
-$21.09M(-5.6%)
Sep 2022
-
-$5.20M(+0.0%)
-$19.97M(+5.0%)
Jun 2022
-
-$5.20M(-4.5%)
-$21.02M(-28.9%)
Mar 2022
-
-$4.98M(-8.6%)
-$16.30M(-16.6%)
Dec 2021
-$13.98M(-60.5%)
-$4.58M(+26.7%)
-$13.98M(-13.8%)
Sep 2021
-
-$6.25M(-1180.9%)
-$12.29M(-53.3%)
Jun 2021
-
-$488.00K(+81.6%)
-$8.02M(+13.3%)
Mar 2021
-
-$2.66M(+8.2%)
-$9.25M(-6.1%)
Dec 2020
-$8.71M(-7.3%)
-$2.89M(-46.3%)
-$8.71M(-7.5%)
Sep 2020
-
-$1.98M(-15.1%)
-$8.10M(+3.2%)
Jun 2020
-
-$1.72M(+19.0%)
-$8.37M(+2.1%)
Mar 2020
-
-$2.12M(+7.1%)
-$8.55M(-5.3%)
Dec 2019
-$8.12M(-749.7%)
-$2.28M(-1.5%)
-$8.12M(-33.3%)
Sep 2019
-
-$2.25M(-18.6%)
-$6.09M(-48.8%)
Jun 2019
-
-$1.90M(-11.9%)
-$4.09M(-69.0%)
Mar 2019
-
-$1.70M(-572.6%)
-$2.42M(-153.5%)
Dec 2018
-$956.00K(-0.4%)
-$252.00K(-0.4%)
-$956.00K(-1.1%)
Sep 2018
-
-$251.00K(-11.6%)
-$946.00K(-0.5%)
Jun 2018
-
-$225.00K(+1.3%)
-$941.00K(+1.9%)
Mar 2018
-
-$228.00K(+5.8%)
-$959.00K(-0.7%)
Dec 2017
-$952.00K(+2.7%)
-$242.00K(+1.6%)
-$952.00K(+4.8%)
Sep 2017
-
-$246.00K(-1.2%)
-$1.00M(-10.9%)
Jun 2017
-
-$243.00K(-10.0%)
-$902.00K(+3.0%)
Mar 2017
-
-$221.00K(+23.8%)
-$930.00K(+4.9%)
Dec 2016
-$978.00K
-$290.00K(-95.9%)
-$978.00K(+1.8%)
DateAnnualQuarterlyTTM
Sep 2016
-
-$148.00K(+45.4%)
-$996.00K(+10.6%)
Jun 2016
-
-$271.00K(-0.7%)
-$1.11M(-2.8%)
Mar 2016
-
-$269.00K(+12.7%)
-$1.08M(-8.4%)
Dec 2015
-$999.00K(-1032.7%)
-$308.00K(-15.8%)
-$999.60K(-32.0%)
Sep 2015
-
-$266.00K(-10.7%)
-$757.00K(-52.6%)
Jun 2015
-
-$240.20K(-29.6%)
-$496.10K(-93.0%)
Mar 2015
-
-$185.40K(-183.5%)
-$257.10K(-191.2%)
Dec 2014
-$88.20K(-1142.3%)
-$65.40K(-1182.4%)
-$88.30K(-251.8%)
Sep 2014
-
-$5100.00(-325.0%)
-$25.10K(+99.6%)
Jun 2014
-
-$1200.00(+92.8%)
-$6.72M(0.0%)
Mar 2014
-
-$16.60K(-654.5%)
-$6.72M(-0.2%)
Dec 2013
-$7100.00(-14.5%)
-$2200.00(+100.0%)
-$6.71M(-0.0%)
Sep 2013
-
-$6.70M(>-9900.0%)
-$6.70M(>-9900.0%)
Jun 2013
-
-$1200.00(+40.0%)
-$6400.00(+5.9%)
Mar 2013
-
-$2000.00(-25.0%)
-$6800.00(-6.3%)
Dec 2012
-$6200.00(-129.6%)
-$1600.00(0.0%)
-$6400.00(-33.3%)
Sep 2012
-
-$1600.00(0.0%)
-$4800.00(+78.9%)
Jun 2012
-
-$1600.00(0.0%)
-$22.80K(+42.9%)
Mar 2012
-
-$1600.00(>-9900.0%)
-$39.90K(+29.3%)
Dec 2011
-$2700.00(+95.4%)
$0.00(+100.0%)
-$56.40K(+50.8%)
Sep 2011
-
-$19.60K(-4.8%)
-$114.60K(-20.6%)
Jun 2011
-
-$18.70K(-3.3%)
-$95.00K(-24.5%)
Mar 2011
-
-$18.10K(+68.9%)
-$76.30K(-31.1%)
Dec 2010
-$58.60K(-4407.7%)
-$58.20K(>-9900.0%)
-$58.20K(>-9900.0%)
Sep 2010
-
$0.00(0.0%)
-$300.00(+50.0%)
Jun 2010
-
$0.00(0.0%)
-$600.00(+33.3%)
Mar 2010
-
$0.00(+100.0%)
-$900.00(+25.0%)
Dec 2009
-$1300.00(0.0%)
-$300.00(0.0%)
-$1200.00(0.0%)
Sep 2009
-
-$300.00(0.0%)
-$1200.00(0.0%)
Jun 2009
-
-$300.00(0.0%)
-$1200.00(0.0%)
Mar 2009
-
-$300.00(0.0%)
-$1200.00(0.0%)
Dec 2008
-$1300.00
-$300.00(0.0%)
-$1200.00(-33.3%)
Sep 2008
-
-$300.00(0.0%)
-$900.00(-50.0%)
Jun 2008
-
-$300.00(0.0%)
-$600.00(-100.0%)
Mar 2008
-
-$300.00
-$300.00

FAQ

  • What is Iovance Biotherapeutics, Inc. annual gross profit?
  • What is the all-time high annual gross profit for Iovance Biotherapeutics, Inc.?
  • What is Iovance Biotherapeutics, Inc. annual gross profit year-on-year change?
  • What is Iovance Biotherapeutics, Inc. quarterly gross profit?
  • What is the all-time high quarterly gross profit for Iovance Biotherapeutics, Inc.?
  • What is Iovance Biotherapeutics, Inc. quarterly gross profit year-on-year change?
  • What is Iovance Biotherapeutics, Inc. TTM gross profit?
  • What is the all-time high TTM gross profit for Iovance Biotherapeutics, Inc.?
  • What is Iovance Biotherapeutics, Inc. TTM gross profit year-on-year change?

What is Iovance Biotherapeutics, Inc. annual gross profit?

The current annual gross profit of IOVA is $17.67M

What is the all-time high annual gross profit for Iovance Biotherapeutics, Inc.?

Iovance Biotherapeutics, Inc. all-time high annual gross profit is $17.67M

What is Iovance Biotherapeutics, Inc. annual gross profit year-on-year change?

Over the past year, IOVA annual gross profit has changed by +$49.61M (+155.33%)

What is Iovance Biotherapeutics, Inc. quarterly gross profit?

The current quarterly gross profit of IOVA is -$2.95M

What is the all-time high quarterly gross profit for Iovance Biotherapeutics, Inc.?

Iovance Biotherapeutics, Inc. all-time high quarterly gross profit is $22.01M

What is Iovance Biotherapeutics, Inc. quarterly gross profit year-on-year change?

Over the past year, IOVA quarterly gross profit has changed by +$2.69M (+47.66%)

What is Iovance Biotherapeutics, Inc. TTM gross profit?

The current TTM gross profit of IOVA is $26.10M

What is the all-time high TTM gross profit for Iovance Biotherapeutics, Inc.?

Iovance Biotherapeutics, Inc. all-time high TTM gross profit is $26.10M

What is Iovance Biotherapeutics, Inc. TTM gross profit year-on-year change?

Over the past year, IOVA TTM gross profit has changed by +$66.90M (+163.98%)
On this page